09:32:05 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Emerald Health Therapeutics Inc
Symbol EMH
Shares Issued 136,997,693
Close 2018-11-21 C$ 3.89
Market Cap C$ 532,921,026
Recent Sedar Documents

Emerald Health names Schmidt as Agro-Biotech president

2018-11-22 07:33 ET - News Release

Mr. Rob Hill reports

EMERALD HEALTH THERAPEUTICS APPOINTS AGRO-BIOTECH PRESIDENT

Emerald Health Therapeutics Inc. has appointed Thierry Schmidt as president of Agro-Biotech, the company's Quebec-based licensed cannabis production operation, effective Nov. 26, 2018. Mr. Schmidt brings 20 years of experience in marketing, brand advocacy, and general management; he has held senior leadership positions at Next Level Energy Inc., L'Oreal Canada and British American Tobacco.

"We welcome Thierry to Agro-Biotech. As a born-and-raised Francophone with deep consumer goods business and marketing expertise, Thierry is ideally positioned to advance Agro-Biotech's strategy to serve patients and consumers in Quebec," said Chris Wagner, chief executive officer, Emerald Health Therapeutics.

"Agro-Biotech and Emerald stand out in the cannabis industry for their extensive experience in life sciences as well as cannabis cultivation and marketing," said Mr. Schmidt. "I look forward to driving a highly competitive production and product strategy for Agro-Biotech."

Mr. Schmidt is a seasoned marketing executive leader with extensive experience in the consumer goods industry. He has held leadership and senior management positions in new business development, operations, sales, investor relations and brand/consumer development. As general manager at L'Oreal and chief marketing officer at Next Level Energy Inc., he managed product development focused on developing a sustainable and profitable business model as well as brand advocacy. Furthermore, in his business development and sales director roles at British American Tobacco, he successfully developed and launched a national trade marketing strategy.

Mr. Schmidt has been granted an option to acquire up to 125,000 common shares vesting over three years.

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics is a Canadian licensed producer of cannabis. Its 50-per-cent-owned Pure Sunfarms joint venture in British Columbia is completing a sophisticated 1.1-million-square-foot greenhouse; its Agro-Biotech operation in Quebec is completing a 75,000-square-foot indoor facility. Commercial production is expanding in both facilities. It secured approximately 500 acres of hemp harvest in 2018 and has contracted for approximately 1,000 acres in 2019 to 2022 with the goal of extracting low-cost cannabidiol (CBD).

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.